ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,724.61
      1.89%
      US Tech 100
      19,404.40
      2.90%
      Dow Jones
      42,080.92
      1.39%
      Brent Oil
      74.185
      2.49%
      Bitcoin
      63,459.05
      2.90%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ

      6. Clarus Therapeutics Holdings Inc (CRXT) Quote

      Clarus Therapeutics Holdings Inc

      Clarus Therapeutics Holdings Inc (CRXT)

      NASDAQ
      0.099
      0.00
      ( 0.00% )
      Updated: 20:00:00
      Delayed by 15 minutes

      Empower your portfolio: Real-time discussions and actionable trading ideas.

      Premium

      Key stats and details

      Current Price
      0.099
      Bid
      0.0912
      Ask
      0.0948
      Volume
      -
      0.00 Day's Range 0.00
      0.00 52 Week Range 0.00
      Previous Close
      0.099
      Open
      -
      Last Trade
      Last Trade Time
      -
      Average Volume (3m)
      -
      Financial Volume
      -
      VWAP
      -

      Ask ADVFN Intelligence (AI)

      CRXT Latest News

      More News

      Clarus Therapeutics Holdings, Inc. Announces Completion of Auction for Sale of JATENZO® and Selection of Tolmar, Inc. as Successful Bidder

      Court-supervised auction for JATENZO (testosterone undecanoate capsules; C-III) concluded on October 14, 2022 NORTHBROOK, Ill., Oct. 18, 2022 (GLOBE NEWSWIRE) -- Clarus Therapeutics Holdings...

      October 18 2022
      GlobeNewswire Inc.

      Clarus Therapeutics Holdings, Inc. Announces Plan for Near-Term Sale of JATENZO® Using Structured Process Through Chapter 11 of the U.S. Bankruptcy Code

      NORTHBROOK, Ill., Sept. 05, 2022 (GLOBE NEWSWIRE) -- Clarus Therapeutics Holdings, Inc. (Clarus) (OTC: CRXT), a pharmaceutical company dedicated to providing solutions to unmet medical needs by...

      September 05 2022
      GlobeNewswire Inc.

      Clarus Therapeutics Reports Second Quarter 2022 Financial and Operating Results and Announces Workforce Reduction

      Second quarter 2022 net revenue increased 46% year-over-year to $4.1 million Second quarter 2022 total prescription growth for JATENZO® increased 23% sequentially and increased 72% year-over-year...

      August 18 2022
      GlobeNewswire Inc.

      Clarus Therapeutics Announces Notice of Allowance for Additional Patent Claims Covering JATENZO® (testosterone undecanoate)

      JATENZO is the first and only FDA-approved oral softgel for testosterone replacement therapy in adult males who have deficient testosterone due to certain medical conditions NORTHBROOK, Ill...

      July 28 2022
      GlobeNewswire Inc.

      Clarus Therapeutics to Present New Data for JATENZO® (testosterone undecanoate) at ENDO 2022, the Endocrine Society’s Annual Meeting

      JATENZO is the first FDA-approved oral softgel for testosterone replacement therapy in adult males who have deficient testosterone due to certain medical conditions NORTHBROOK, Ill., June 09...

      June 09 2022
      GlobeNewswire Inc.

      Clarus Therapeutics Announces Issuance of Patent Covering JATENZO® (testosterone undecanoate)

      JATENZO is the first FDA-approved oral softgel for testosterone replacement therapy in adult males who have deficient testosterone due to certain medical conditions Clarus plans to list this...

      May 18 2022
      GlobeNewswire Inc.

      Clarus Therapeutics Reports First Quarter 2022 Financial and Operating Results

      First quarter 2022 net revenue increased 72% year-over-year to $4.0 million First quarter 2022 total prescription growth for JATENZO® increased 12% sequentially and increased 75% year-over-year...

      May 16 2022
      GlobeNewswire Inc.

      Clarus Therapeutics to Report First Quarter 2022 Financial and Operating Results

      NORTHBROOK, Ill., May 12, 2022 (GLOBE NEWSWIRE) -- Clarus Therapeutics Holdings, Inc. (“Clarus”) (Nasdaq:CRXT), a pharmaceutical company dedicated to providing solutions to unmet medical needs...

      May 12 2022
      GlobeNewswire Inc.

      Clarus Therapeutics Announces Notice of Allowance for Patent Claims Covering CLAR-121 (Testosterone + Anastrozole) for Treatment of Androgen-Mediated Autoimmune Inflammatory Mastitis

      Initial focus for CLAR-121 is the treatment of periductal mastitis (PDM) in women Clarus is seeking Orphan Drug Designation from the U.S. Food and Drug Administration (FDA) in the second quarter...

      May 10 2022
      GlobeNewswire Inc.

      Clarus Therapeutics to Present New Data for JATENZO® (testosterone undecanoate) at the 2022 American Urological Association Annual Meeting

      JATENZO is the first FDA-approved oral softgel for testosterone replacement therapy in adult males who have deficient testosterone due to certain medical conditions NORTHBROOK, Ill., May 09...

      May 09 2022
      GlobeNewswire Inc.
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      10000000CS
      40000000CS
      120000000CS
      260000000CS
      520000000CS
      1560000000CS
      2600000000CS

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      ZEOZeo Energy Corporation
      $ 2.39
      (109.65%)
      		56.14M
      GSIWGarden Stage Ltd
      $ 4.695
      (106.83%)
      		43.87M
      TBIOTelesis Bio Inc
      $ 2.71
      (99.26%)
      		49.64M
      XCURExicure Inc
      $ 3.73
      (62.88%)
      		15.83M
      GLMDGalmed Pharmaceuticals Ltd
      $ 10.8755
      (57.62%)
      		31.98M
      HAOHaoxi Health Technology Ltd
      $ 0.745
      (-75.17%)
      		6.65M
      HOVRNew Horizon Aircraft Ltd
      $ 0.456
      (-38.46%)
      		2.4M
      GDHGGolden Heaven Group Holdings Ltd
      $ 2.72
      (-34.77%)
      		430.14k
      PGNYProgyny Inc
      $ 16.70
      (-31.67%)
      		12.39M
      BLMZBloomZ Inc
      $ 0.95
      (-30.66%)
      		610.84k
      NVDANVIDIA Corporation
      $ 119.38
      (5.30%)
      		176.4M
      SQQQProShares UltraPro Short QQQ
      $ 7.6797
      (-8.58%)
      		150.07M
      MAXNMaxeon Solar Technologies Ltd
      $ 0.10155
      (11.72%)
      		84.45M
      FRGTFreight Technologies Inc
      $ 0.128
      (3.31%)
      		75.6M
      TSLATesla Inc
      $ 243.24
      (7.06%)
      		67.52M

      Discussion

      View Full Feed
      cintrix cintrix 5 minutes ago
      PGNY down 32% - losing a major client
      musicman 1 musicman 1 5 minutes ago
      That’s because this company is a scam. Sorry. I’m in the grave with all of you
      DRNK
      Ripper7 Ripper7 5 minutes ago
      You filled out the board and knocked out the message from the guy who spoke to Mesa Rep twice. He said Mesa was considering filing and bringing it up to date. He may have said that to deter s/h legal action.
      GBHL
      tdbowieknife tdbowieknife 5 minutes ago
      Marc's likely on the phone with the painters now...


      ..


      Buyer Beware
      Pump and dump
      http://images.investorshub.advfn.com/images/uploads/2013/12/13/fowqcCaveat_Emptor_5.JPG


      .
      IFUS
      Alley-oop Alley-oop 6 minutes ago
      Great! SMC announced the retirement of $879,759 combined debt, which will be reflected in Q2 and Q3.
      SMCE
      RobotDroid RobotDroid 6 minutes ago
      Best to not suffer that fool.
      NWBO
      jbsliverer jbsliverer 6 minutes ago
      https://x.com/HouseJudiciary/status/1836816228779803086


      .
      EOT EOT 6 minutes ago
      Now what. There’s no hate in there. How’s that gonna fit a narrative for the emotional minded so easily convinced otherwise?

      Peace means prosperity EVERYWHERE $$
      XRPUSD
      peafunke peafunke 6 minutes ago
      Afternoon Jake and all. What’s in Schrödinger’s box?
      TPTW
      jxyzobrien jxyzobrien 6 minutes ago
      shane next

      https://www.youtube.com/watch?v=1prebDgjW-o
      Monksdream Monksdream 6 minutes ago
      ADD next lowest priced issue making a new high
      https://investorshub.advfn.com/uimage/uploads/2024/9/19/gqhupIMG_1921.gif
      Hawkeiz Hawkeiz 7 minutes ago
      Looks great let's go!
      SINC
      bas2020 bas2020 7 minutes ago
      Even through all your ad nauseum complaints and whining, you continue to be a shareholder. You apparently believe this is a great investment or you would've sold long ago. Though, not sure why anyone who is sincere in their outward complaints and mistrust of mgt is still a shareholder. Perhaps no
      NWBO
      Debunkinator Debunkinator 7 minutes ago
      Bid is building :) Lets go
      ASII
      Deano361 Deano361 7 minutes ago
      True , very true
      FUNR
      RobotDroid RobotDroid 7 minutes ago
      Lot of dummies here. DI and company are simply the worst. Never ever seen a company go so silent when the stock constantly tanks daily. Nonmanagement is a stinking POS.
      NWBO
      nyt nyt 7 minutes ago
      Keep that up and you be eating Kemps frozen fish sticks....
      VPLM
      SeniorApollo SeniorApollo 7 minutes ago
      You can sue for anything, and chances are he won't show up anyway.
      NSAV
      Longer Than Most Longer Than Most 7 minutes ago
      Love to see it. Hope they can get this back. Nice dump today AIAD
      AIAD
      mascale mascale 8 minutes ago
      Per HIRU mining website: "OTC:Hiru Non news worthy announcements and updates will be posted here temporarily until our OTC MARKETS access is resumed shortly. " Many X-posts document that progress, alone.
      HIRU
      Prudent Capitalist Prudent Capitalist 8 minutes ago
      Bingo! Welcome passengers to the SS DJTitanic. Please ensure you have a life vest and a plan...We WILL be sinking soon

      Investors win lawsuit vs DJT. More selling incoming!
      https://www.cnbc.com/2024/09/17/djt-trump-media-stock-lawsuit-lockup.html

      In a Florida law
      DJT
      Tesla Trillionaire Tesla Trillionaire 8 minutes ago
      Massive day.
      TSLA
      HokieHead HokieHead 8 minutes ago
      Nice, should see money flow back in here as the other “we have to chase” plays are imploding.

      Real deal here, crazy to leave with all that’s coming imo.
      BNCM
      fung_derf fung_derf 8 minutes ago
      Yeah, I liked him.
      Considering how many of the people are either Survivor bloggers or read books on how to win, perhaps the show has been on too long
      I-Glow I-Glow 8 minutes ago
      Just saying - "Undervalued! Fair value is $0.013" is meaningless pumping.

      Post the details at how you arrived at the valuation. Which valuation method did you use?

      IG
      FORW

      Your Recent History

      NASDAQ
      CRXT
      Clarus Therapeutics
      Delayed Upgrade Clock